MANTEL TECHNOLOGIES, INC. — Department of Defense SBIR Phase II: SOCOM163-007

Description

Military working dogs (MWD) are combat multipliers that provide essential detection and force protection capabilities to Special Operations Forces and units within each of the armed service branches serving globally every day. Every deployment includes planning requirements for medical support under austere conditions with limited or delayed evacuation assets. Although blood products are useful for a range of combat and non-combat related injuries and diseases, there are major impediments to the maintenance of deployed fresh whole blood, fresh frozen plasma and even plasma apheresis programs including: cold chain and refrigeration requirements, lack of several laboratory analysis capabilities; lack of organic equipment and training; and, the unavoidable requirement to keep MWD blood shipment and handling unequivocally separate from any human blood components. The development of shelf-stable canine blood products solves the current logistic and training issues and pushes this life-saving capability to forward deployed veterinary and human health care providers responsible for the continuum of MWD care from the point of injury through strategic evacuation. To address the current need Mantel Technologies has developed a prototype Canine Freeze-Dried Plasma (cFDP) kit that contains everything required to administer reconstituted canine plasma in the field.